Certainly, although further studies are needed here to unravel the consequences and identify potential therapeutic approaches, our here identified differences in platelet functionality and their progenitors support the concept that megakaryocytes effectively confer immune functions in RA and SLE (49) which are altered upon C3 treatment. This evidence concerns the gene C3 and systemic lupus erythematosus.